Halide Alagoz - 27 Aug 2025 Form 4 Insider Report for RALPH LAUREN CORP (RL)

Role: Chief Product Officer
Signature: /s/ Avery S. Fischer, Attorney-in-Fact for Halide Alagoz
Issuer symbol: RL
Transactions as of: 27 Aug 2025
Net transactions value: -$1,558,190
Form type: 4
Filing time: 28 Aug 2025, 17:34:58 UTC
Previous filing: 19 Aug 2025
Next filing: 05 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Alagoz Halide	Chief Product Officer	RALPH LAUREN CORPORATION, 650 MADISON AVENUE, NEW YORK	/s/ Avery S. Fischer, Attorney-in-Fact for Halide Alagoz	28 Aug 2025	0001940924

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RL	Class A Common Stock	Sale	$1,558,190	-5,282	-17%	$295.00	26,452	27 Aug 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was made in connection with a long-term strategy for estate planning and investment diversification.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.00 to $295.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Content

This sale was made in connection with a long-term strategy for estate planning and investment diversification.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.00 to $295.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.